___

• 1. Vincent, J.L., Rello, J., Marshall, J., Silva, E., Anzueto, A., Martin, C.D., Reinhart, K. (2009). International study of the prevalence and outcomes of infection in intensive care units. Jama, 302(21), 2323-2329. [CrossRef]
• 2. Roca, I., Espinal, P., Vila-Farrés, X., Vila, J. (2012). The Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace. Frontiers in Microbiology, 3, 148-169. [CrossRef]
• 3. Kiyasu, Y., Hitomi, S., Funayama, Y., Saito, K., Ishikawa, H. (2020). Characteristics of invasive Acinetobacter infection: A multicenter investigation with molecular identification of causative organisms. Journal of Infection and Chemotherapy, 26(5), 475-482. [CrossRef]
• 4. Lima, W.G., Alves, M.C., Cruz, W.S., Paiva, M.C. (2018). Chromosomally encoded and plasmid-mediated polymyxins resistance in Acinetobacter baumannii: a huge public health threat. European Journal of Clinical Microbiology and Infectious Diseases, 37(6), 1009-1019. [CrossRef]
• 5. An, J.H., Kim, Y.H., Moon, J.E., Jeong, J.H., Kim, S.H., Kang, S.J., Jang, H.C. (2017). Active surveillance for carbapenem-resistant Acinetobacter baumannii in a medical intensive care unit: Can it predict and reduce subsequent infections and the use of colistin?. American Journal of Infection Control, 45(6), 667-672. [CrossRef]
• 6. Antunes, L.C., Visca, P., Towner, K.J. (2014). Acinetobacter baumannii: evolution of a global pathogen. Pathogens and Disease, 71(3), 292-301. [CrossRef]
• 7. Maleki, A., Vandyousefi, J., Mirzaie, Z., Ghafourian, S., Kazemian, H., Sadeghifard, N. (2017). Molecular Analysis of the Isolates of Acinetobacter baumannii isolated from Tehran Hospitals Using ERIC-PCR Method. Modern Medical Laboratory Journal, 1(1), 12-16. [CrossRef]
• 8. Aljindan, R., Alsamman, K., Elhadi, N. (2018). ERIC-PCR genotyping of Acinetobacter baumannii isolated from different clinical specimens. Saudi Journal of Medicine and Medical Sciences, 6(1), 13-17. [CrossRef]
• 9. Testing EUCAST (2016). EUCAST disk diffusion test manual, version 4.0. [CrossRef]
• 10. European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 10.0, valid from 2020-01-01. Basel, Switzerland: EUCAST [accessed 15 Mart 2020].
• 11. Dorneles, E.M., Santana, J.A., Ribeiro, D., Dorella, F.A., Guimaraes, A.S., Moawad, M.S., Lage, A.P. (2014). Evaluation of ERIC-PCR as genotyping method for Corynebacterium pseudotuberculosis isolates. PLoS One, 9(6), e98758. [CrossRef]
• 12. McConnell, M.J., Actis, L., Pachon, J. (2013). Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models. FEMS Microbiol Review, 37(2), 130-155. [CrossRef]
• 13. Fishbain, J., Peleg, A.Y. (2010). Treatment of Acinetobacter infections. Clinical Infectious Diseases, 51(1), 79-84. [CrossRef]
• 14. Karaoglan, I., Zer, Y., Bosnak, V.K., Mete, A.O., Namiduru, M. (2013). In vitro synergistic activity of colistin with tigecycline or beta-lactam antibiotic/beta-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii. Journal of International Medical Research, 41(6), 1830-1837. [CrossRef]
• 15. Principe, L., D'Arezzo, S., Capone, A., Petrosillo, N., Visca, P. (2009). In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii. Annals of Clinical Microbiology and Antimicrobials, 8, 18-29. [CrossRef]
• 16. Zarifi, E., Ghazalibina, M., Mansouri, S., Morshedi, K., Pourmajed, R., Arfaatabar, M. (2020). Molecular typing of Acinetobacter baumannii clinical strains by enterobacterial repetitive intergenic consensus polymerase chain reaction (ERIC-PCR). Gene Reports, 18, 100542. [CrossRef]
• 17. Hazhirkamal, M., Zarei, O., Movahedi, M., Karami, P., Shokoohizadeh, L., Taheri, M. (2021). Molecular typing, biofilm production, and detection of carbapenemase genes in multidrug-resistant Acinetobacter baumannii isolated from different infection sites using ERIC-PCR in Hamadan, west of Iran. BMC pharmacology and toxicology, 22(1), 32-32. [CrossRef]
• 18. Falah, F., Shokoohizadeh, L., Adabi, M. (2019). Molecular identification and genotyping of Acinetobacter baumannii isolated from burn patients by PCR and ERIC-PCR. Scars, Burns and Healing, 5, 2059513119831369. [CrossRef]
• 19. Gautam, H., Maheshwari, B., Mohapatra, S., Sood, S., Dhawan, B., Kapil, A., Tezpur, B. (2022). Clonal relationship among Acinetobacter baumannii isolates from different clinical specimens by ERIC-PCR. International Journal of Infectious Diseases, 116, S18-S19. [CrossRef]
• 20. Lotfi, F., Shojaie, M., Rahbarnia, L., Dehnad, A., Naghili, B., Lotfi, H. (2022). Molecular characterization and genetic diversity of multidrug- and extensively drug-resistant A. baumannii clinical isolates. Gene Reports, 26, 101455. [CrossRef]